3.36
0.09 (2.75%)
0.09 (2.75%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptinyx Inc | APTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.09 | 2.75% | 3.36 | 19:55:22 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.29 | 3.243 | 3.41 | 3.36 | 3.27 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.33 | 3.36 | 0.03 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,821 | 807,328 | $ 3.32 | $ 2,679,303 | 2,795,499 | 1.60 - 6.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:39 | 44 | $ 3.36 | USD |
Aptinyx Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 212.54M | 63.26M | 43.90M | $ 3.67M | $ - | -1.71 | -2.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 2.40% |
Aptinyx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.11 | 3.41 | 2.98 | 3.16 | 559,116 | 0.25 | 8.04% |
| 1 Month | 3.07 | 3.42 | 2.81 | 3.12 | 967,897 | 0.29 | 9.45% |
| 3 Months | 3.26 | 6.47 | 2.81 | 3.82 | 1,427,574 | 0.10 | 3.07% |
| 6 Months | 4.40 | 6.47 | 2.81 | 3.88 | 849,541 | -1.04 | -23.64% |
| 1 Year | 3.10 | 6.47 | 1.60 | 3.80 | 562,931 | 0.26 | 8.39% |
| 3 Years | 17.40 | 32.25 | 1.60 | 5.69 | 359,360 | -14.04 | -80.69% |
| 5 Years | 17.40 | 32.25 | 1.60 | 5.69 | 359,360 | -14.04 | -80.69% |
Aptinyx Description
| Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder. |
